1
/
of
1
Elabscience
SKU:PKSH032214
Recombinant Human CD40L/TNFSF5 Protein (Human Cells)(Active)
Recombinant Human CD40L/TNFSF5 Protein (Human Cells)(Active)
Regular price
$200.00 USD
Regular price
Sale price
$200.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant Human CD40L/TNFSF5 Protein, derived from human cells, boasting an active composition. This meticulously crafted protein exhibits exceptional quality and efficacy, making it an indispensable tool for various research and therapeutic applications.
Our Recombinant Human CD40L/TNFSF5 Protein is meticulously produced using cutting-edge biotechnological techniques, ensuring the utmost purity and bioactivity. Derived from human cells, this protein offers an unparalleled level of authenticity, closely resembling the natural form found within the human body.
With its active nature, this protein serves as a potent activator of CD40, a crucial receptor involved in immune responses and cell signaling pathways. By engaging CD40, our Recombinant Human CD40L/TNFSF5 Protein facilitates the activation of immune cells, promoting enhanced immune responses and facilitating the exploration of intricate immunological mechanisms.
This product's exceptional quality is further exemplified by its rigorous quality control measures, guaranteeing batch-to-batch consistency and reproducibility. Each vial of Recombinant Human CD40L/TNFSF5 Protein is meticulously tested to ensure optimal bioactivity, purity, and stability, providing researchers and clinicians with reliable and consistent results.
The versatility of our Recombinant Human CD40L/TNFSF5 Protein extends to a wide range of applications, including but not limited to immunology research, vaccine development, and therapeutic interventions. Its active composition and reliable performance make it an invaluable asset in elucidating complex immunological processes and designing novel therapeutic strategies.
In summary, our Recombinant Human CD40L/TNFSF5 Protein, derived from human cells and boasting an active formulation, stands as a pinnacle of quality and efficacy. With its exceptional purity, bioactivity, and versatility, this product serves as an indispensable tool for researchers and clinicians alike, enabling groundbreaking discoveries and advancements in the field of immunology.
Our Recombinant Human CD40L/TNFSF5 Protein is meticulously produced using cutting-edge biotechnological techniques, ensuring the utmost purity and bioactivity. Derived from human cells, this protein offers an unparalleled level of authenticity, closely resembling the natural form found within the human body.
With its active nature, this protein serves as a potent activator of CD40, a crucial receptor involved in immune responses and cell signaling pathways. By engaging CD40, our Recombinant Human CD40L/TNFSF5 Protein facilitates the activation of immune cells, promoting enhanced immune responses and facilitating the exploration of intricate immunological mechanisms.
This product's exceptional quality is further exemplified by its rigorous quality control measures, guaranteeing batch-to-batch consistency and reproducibility. Each vial of Recombinant Human CD40L/TNFSF5 Protein is meticulously tested to ensure optimal bioactivity, purity, and stability, providing researchers and clinicians with reliable and consistent results.
The versatility of our Recombinant Human CD40L/TNFSF5 Protein extends to a wide range of applications, including but not limited to immunology research, vaccine development, and therapeutic interventions. Its active composition and reliable performance make it an invaluable asset in elucidating complex immunological processes and designing novel therapeutic strategies.
In summary, our Recombinant Human CD40L/TNFSF5 Protein, derived from human cells and boasting an active formulation, stands as a pinnacle of quality and efficacy. With its exceptional purity, bioactivity, and versatility, this product serves as an indispensable tool for researchers and clinicians alike, enabling groundbreaking discoveries and advancements in the field of immunology.
Share
